152 related articles for article (PubMed ID: 12174883)
1. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol.
Hsieh TC; Xiong W; Traganos F; Darzynkiewicz Z; Wu JM
Anticancer Res; 2002; 22(4):2051-60. PubMed ID: 12174883
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
Lu X; Guo J; Hsieh TC; Wu JM
Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
4. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
[TBL] [Abstract][Full Text] [Related]
5. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES.
Hsieh T; Chen SS; Wang X; Wu JM
Biochem Mol Biol Int; 1997 Jul; 42(3):535-44. PubMed ID: 9247711
[TBL] [Abstract][Full Text] [Related]
6. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
[TBL] [Abstract][Full Text] [Related]
7. Prevention and management of prostate cancer using PC-SPES: a scientific perspective.
Hsieh TC; Lu X; Chea J; Wu JM
J Nutr; 2002 Nov; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879
[TBL] [Abstract][Full Text] [Related]
8. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
9. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
10. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
Bonham M; Arnold H; Montgomery B; Nelson PS
Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
[TBL] [Abstract][Full Text] [Related]
11. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
[TBL] [Abstract][Full Text] [Related]
12. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
Bonham MJ; Galkin A; Montgomery B; Stahl WL; Agus D; Nelson PS
J Natl Cancer Inst; 2002 Nov; 94(21):1641-7. PubMed ID: 12419791
[TBL] [Abstract][Full Text] [Related]
13. In vitro mechanism of PC SPES.
Chenn S
Urology; 2001 Aug; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443
[TBL] [Abstract][Full Text] [Related]
14. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE
J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371
[TBL] [Abstract][Full Text] [Related]
15. Ethanolic extracts of herbal supplement Equiguard suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status.
Hsieh TC; Wu JM
Int J Oncol; 2008 Jan; 32(1):209-19. PubMed ID: 18097561
[TBL] [Abstract][Full Text] [Related]
16. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer.
Oh WK; George DJ; Hackmann K; Manola J; Kantoff PW
Urology; 2001 Jan; 57(1):122-6. PubMed ID: 11164156
[TBL] [Abstract][Full Text] [Related]
17. PC-SPES inhibits colon cancer growth in vitro and in vivo.
Huerta S; Arteaga JR; Irwin RW; Ikezoe T; Heber D; Koeffler HP
Cancer Res; 2002 Sep; 62(18):5204-9. PubMed ID: 12234985
[TBL] [Abstract][Full Text] [Related]
18. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
20. Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.
Oh WK; George DJ; Kantoff PW
Cancer; 2002 Feb; 94(3):686-9. PubMed ID: 11857300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]